29 June 2020
Latham & Watkins advises Castle Biosciences in its US$74 Million Public Offering of Common Stock
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Wesley Holmes Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Anthony Gostanian | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Kiara Vaughn | Latham & Watkins LLP | Associate | capital markets | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 74m (US$74.0 million)
- What the figure measures
- Issue size
- Client
- Castle Biosciences, Inc.Issuer
- Counterparties
- Not stated